Share Name Share Symbol Market Type Share ISIN Share Description
Medica Group plc LSE:MGP London Ordinary Share GB00BYV24996 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  +4.00p +2.70% 152.00p 24,630 11:32:24
Bid Price Offer Price High Price Low Price Open Price
145.20p 152.00p 152.00p 150.00p 150.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 33.72 5.66 3.99 38.1 168.9

Medica Grp (MGP) Latest News

More Medica Grp News
Medica Grp Takeover Rumours

Medica Grp (MGP) Share Charts

1 Year Medica Grp Chart

1 Year Medica Grp Chart

1 Month Medica Grp Chart

1 Month Medica Grp Chart

Intraday Medica Grp Chart

Intraday Medica Grp Chart

Medica Grp (MGP) Discussions and Chat

Medica Grp Forums and Chat

Date Time Title Posts
05/8/201820:37Medica Group462
04/8/200913:33Mercury Group: Charts and Comment254
24/7/200815:11Mercury Group...A New Beginning.668
14/10/200517:59Mercury Group (Old Cater Barnard) A New Beginning254
16/4/200407:53Make My Day5

Add a New Thread

Medica Grp (MGP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
12:03:00152.002030.40AT
12:01:58151.932,0003,038.64O
11:03:42152.002233.44AT
11:02:22152.00152231.04UT
10:32:24152.004974.48AT
View all Medica Grp trades in real-time

Medica Grp (MGP) Top Chat Posts

DateSubject
15/8/2018
09:20
Medica Grp Daily Update: Medica Group plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MGP. The last closing price for Medica Grp was 148p.
Medica Group plc has a 4 week average price of 111p and a 12 week average price of 111p.
The 1 year high share price is 233p while the 1 year low share price is currently 111p.
There are currently 111,111,114 shares in issue and the average daily traded volume is 68,375 shares. The market capitalisation of Medica Group plc is £168,888,893.28.
23/7/2018
21:07
andygibb101: If he got elected then the share price of MGP would be the least of your worries.
14/6/2018
17:36
ayesha4: Your source is a radiologist? Nighthawk per radiologist is the same. What your contact will not know is that the number of radiologists per shift has gone up dramatically. Three clients waiting in the wings also pending further recruitment. Dayhawk also the same. The share price is going down - the business is doing very well indeed. Get your contact to speak with one of the management to see how the business is doing and feed back to you. He will repeat what I have said.
10/5/2018
15:23
aishah: This investment trust has a really clever way of picking stocks Strategic Equity Capital taps into a network of experts as well as carrying out specific financial analysis Medica (MGP) grew very strongly at 18% organically last year but the market was expecting 22%, which led to a fall in its share price. There was a slowdown in the fourth quarter due to NHS capacity issues during the winter crisis. However, the fund manager notes the long term structural drivers are strong and Medica is the market leader. He adds that it continues to offer double digit earnings growth and is trading on a PEG ratio of less than 1-times which implies it is cheap. ‘Its cash flow yield is very strong and it has no debt. Our position was reduced last year as it re-rated but this year we’ve been buying back on weakness.’ httPs://www.sharesmagazine.co.uk/article/this-investment-trust-has-a-really-clever-way-of-picking-stocks
17/1/2018
23:29
thebigshortfella: Hey Velod, Re: "coincidence or what?" I don't think so. I got burnt on VLS on Monday due to the deeply discounted share placing. From 27p to 10p! Now...I noticed on Friday that 10% of IG Index clients with VLS trades had shorts on VLS. This is highly unusual from what I have seen. Obviously I can't prove it but I am convinced that some traders new about the discounted share price... With regards to Medica, I just checked and 8% of IG Index's clients with trades on MGP have shorts. Not good... Re: could only come from a disgruntled ex employee. I recall it. It did make me wonder at the time if the business had some significant operational issues. I have even researched some of the staff on LinkedIn and they don't look hugely impressive. I placed a trade at 227 and it cost me £30k...Ouch... Re: very, very, worrying. It could well be. I am starting to think that the MGP story is just that...I am glad that my trade ended on 19th December. I would have lost a lot more money if I had been in it... BTW I sent you a private message. Thanks!
22/10/2017
21:37
dibbs: Good post Velod. I think you have pretty much hit the nail on the head! I bought MGP thinking it would be a nice long term hold but with the hope that the share price would have appreciated a little more than it has by now! I bought around May when the chart looked pretty good and I thought there was some momentum evident but that soon fizzled out after my purchases! With hindsight I was a little hasty in taking a position as the PE is pretty rich. I have decided that MGP has loads of positives and with the advancement of time, coupled with IMHO a greater risk of an upside earnings surprise than downside that I would stay put. Hopefully future events here will make me a happier shareholder and persuade you that MGP is on the move! Cheers Dibbs
20/10/2017
22:08
velod: This post in response to The BigShortFella’s request to me on another forum and is in reply to BSFella. Have no position in this share, nor intention to take one, but now it’s been brought to my attention might put it on a watchlist somewhere, out of sheer Nosey-Parker-interest on my part. Hi BSFella, Had the impression you were a micro-cap guy so surprised this is a quarter billion-pound MCap company. As a trend follower, no I would not buy this, at this juncture, based solely on the share price action alone. Momentum is iffy; albeit with a recent bull trend initiated, but it’s yet to be established if THIS TIME it will hold and build. Can’t understand why as the company as distinct from the share price appears to be a right little belter. Have access to the Piotroski F-Score and (if anyone hasn’t heard of that just Google) was gobsmacked at how MGP, the business, scored. It only goes and achieves top marks! Not only top marks but flying colours too, kind of top Marks! The highest a company can achieve is 9 - and MGP is rated a right royal gold standard 9. You can’t get higher. And that tells me this is one well-run, mean machine business. That being the case, what the hell’s happened to the share price momentum? I’m not built for fundamentals, but things like Return On Capital and ROE are excellent – no wonder it scored so highly on the F-Score. The business per se, independent of the share price rating, is a stonking belter! So why am I not interested? The share price soared until mid-summer. What happened at the height of summer? Because since then the share price has been unimpressive. Why has the market withdrawn its admiration by turning its back on the SP? And why that big retrace today, Friday? Perhaps I should read the posts below; somebody must have an idea. Why has the market withdrawn its initial embrace? Is it the PE ratio? Does the market think the current PE ratio is unworthy and is holding back? It is above the market average but not that much, (Edit, Upon reflection, well - yes that much. It is a 'fair bit' above the average). Unless I trawled through analysts reports something about this share price level, irks the market. Trendlines: It is currently on a little bull rally, but it’s been on and off all summer like that and looks disappointing to me. I, personally don’t trust the share price so wouldn’t take a long position. nor a short position because the share price has no real momentum for either strategy to be reliable. Until a clear trend breaks AND holds it’s a sit it out on the side-lines job for me with this one. Great company. Rubbish share price momentum.
04/10/2017
11:04
dibbs: Some big trades gone through and the share price has edged upwards. Perhaps an overhang of stock cleared....Dibbs
18/9/2017
23:19
glasshalfull: The share price was down today because MGP failed to deliver sales in line with Investec's forecasts. Investec believe however that full year forecasts can be achieved. "H1 sales were weaker than we expected due to capacity constraints and the timing of contract renewals. Revenues rose 17%, with 6.5% growth in body parts reported. However x-ray sales fell 8% as resources were directed towards the higher value services. The company recruited a net 19 radiologists in the period, with a further 24 added post period-end, consequently we are confident FY estimates can be achieved." --- Hope this assists. I don't hold. Kind regards GHF
07/9/2017
16:10
lomax99: Shares magazine Medica is a premium growth story The NHS does not have enough radiologists to interpret potentially life-saving scans Teleradiology firm Medica (MGP) is expected to enjoy rapid growth thanks to a surge in demand and a lack of radiologists in the UK. Medica helps to provide early diagnosis of various diseases through its consultant radiologists who interpret computerised tomography (CT) and magnetic resonance imaging (MRI) scans. If these scans identify diseases earlier, it can improve treatment options and outcomes. Strong performance since IPO Berenberg says earnings before interest, tax, depreciation and amortisation and earnings per share are expected to grow at a compound annual growth rate of 16% and 20% respectively between 2017 and 2020. Medica has enjoyed a strong share price performance since its IPO on 21 March 2017 when it raised £121m to pay down borrowings. Since 22 March, the stock has rallied 16.9% to 219.2p. The company currently trades on a forecast 29.8 times earnings per share in the year to 31 December 2018, but Berenberg analyst Charles Weston thinks this premium valuation is ‘justifiedR17; in light of rapid growth. The analyst projects 8% growth per annum in the volume of CT and MRI scans handled by the company, which will be supported by a deficit of radiologists in the UK. There are 4.7 radiologists per 100,000 of the UK general population. This is materially below the Royal College of Radiologists’ target of 8 per 100,000, and is pushing up waiting lists. Outsourcing trends and pricing power One of the ways to tackle this issue is by outsourcing services. Weston says approximately 7% of CT/MRI scans are outsourced. Medica has a dominant position in the UK teleradiology market (50%) and this allows it to charge 5% to 10% more than its rivals. The analyst also highlights that 80% of all clinical decisions are underpinned by imaging and new clinical guidelines for quicker diagnosis of diseases such as cancer and dementia call for scans. Medica provides services to over 100 NHS trusts, as well as private hospitals and diagnostics imaging firms, and intends to expand its services to tackles conditions such as strokes. There are risks associated with the business. Medica needs to ensure it continues to recruit radiologists to meet demand as otherwise growth could be constrained. We were initially cautious on Medica’s dependence on the NHS and Weston also highlights the NHS exposure as a reason for some caution as 99% of sales are derived from NHS Trusts. Despite this nagging concern we are convinced high demand and low supply will drive Medica forward.
22/8/2017
21:56
thebigshortfella: Dan_the_Epic - I like the fact that you are challenging MGP. Am I right in assuming that you wouldn't trade MGP at its current share price?
Medica Grp share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180815 13:06:03